Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion by Lynch, J. et al.
Article
The Rockefeller University Press 




Severe respiratory syncytial virus (RSV)–bronchiolitis is a 
major cause of morbidity and mortality in infants globally 
(Nair et al., 2010) and a major independent risk factor (i.e., 
in the absence of atopy) for asthma (extensively reviewed in 
Feldman et al. [2015]). A recent population study examin-
ing two large cohorts estimated that 13% of all asthma cases 
stem from RSV-bronchiolitis in infancy (James et al., 2013), 
suggesting that a better understanding of the underlying 
mechanisms will identify opportunities for new preventative 
therapies. RSV-bronchiolitis primarily affects children aged 
under 2 yr (Hall, 2001), and asthma most often commences 
in childhood, highlighting a window of susceptibility in early 
life. This period coincides with the postnatal assembly of the 
microbiota (Yatsunenko et al., 2012; Planer et al., 2016), an 
event that is integral to the development of host physiology 
and immune cell maturation, including the differentiation 
of regulatory T (T reg) cells (Hooper et al., 2012; Arpaia 
et al., 2013; Furusawa et al., 2013). However, whether the 
respiratory syncytial virus–bronchiolitis is a major independent risk factor for subsequent asthma, but the causal mechanisms 
remain obscure. We identified that transient plasmacytoid dendritic cell (pdc) depletion during primary Pneumovirus infection 
alone predisposed to severe bronchiolitis in early life and subsequent asthma in later life after reinfection. pdc depletion ab-
lated interferon production and increased viral load; however, the heightened immunopathology and susceptibility to subse-
quent asthma stemmed from a failure to expand functional neuropilin-1+ regulatory t (t reg) cells in the absence of pdc-derived 
semaphorin 4a (Sema4a). In adult mice, pdc depletion predisposed to severe bronchiolitis only after antibiotic treatment. 
consistent with a protective role for the microbiome, treatment of pdc-depleted neonates with the microbial-derived metab-
olite propionate promoted Sema4a-dependent t reg cell expansion, ameliorating both diseases. In children with viral bronchi-
olitis, nasal propionate levels were decreased and correlated with an IL-6high/IL-10low microenvironment. We highlight a 
common but age-related Sema4a-mediated pathway by which pdcs and microbial colonization induce t reg cell expansion to 
protect against severe bronchiolitis and subsequent asthma.
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age-related development of the microbiota affects susceptibil-
ity to RSV-bronchiolitis remains unknown.
In response to respiratory virus infection, plasmacytoid 
dendritic cells (DCs [pDCs]) are recruited to the lungs and 
produce vast amounts of antiviral IFNα and IFNβ downstream 
of TLR7 activation (Swiecki and Colonna, 2015). Notably, 
pDCs contribute to T reg cell development in both thy-
mus and periphery (de Heer et al., 2004; Martín-Gayo et al., 
2010), and hence contribute to immunoregulation. Numbers 
of circulating pDCs in infancy are inversely correlated with 
lower respiratory tract infections and physician-diagnosed 
asthma at school age (Silver et al., 2009; Upham et al., 2009), 
and in vitro studies with peripheral blood mononuclear cells 
show that pDCs limit type 2 cytokine production after stim-
ulation with a respiratory virus (Pritchard et al., 2012). RSV 
does not infect pDCs or affect pDC survival, but it can im-
pair IFN production (Hornung et al., 2004; Schlender et al., 
2005; Guerrero-Plata et al., 2006; Schijf et al., 2013). Anti-
body-mediated depletion of pDCs increases the magnitude 
of type 2 inflammation to RSV infection in adult mice, al-
though this phenotype was not ameliorated by IFNα admin-
istration (Smit et al., 2006; Wang et al., 2006). Intriguingly, T 
reg cell function is impaired in RSV-bronchiolitis (Raiden 
et al., 2014; Christiaansen et al., 2016), and in neonatal mice, 
RSV infection was shown to diminish tolerance via an effect 
on T reg cells (Krishnamoorthy et al., 2012). TLR7 poly-
morphisms are linked to asthma risk, and TLR7 hyporespon-
siveness is evident in subjects with asthma (Møller-Larsen et 
al., 2008; Roponen et al., 2010). Infection with pneumonia 
virus of mice (PVM), a mouse-specific Pneumovirus of the 
same genus as RSV, in the absence of Tlr7 predisposes to 
severe bronchiolitis in mice, whereas the adoptive transfer of 
Tlr7-sufficient pDC to Tlr7-deficient mice confers protec-
tion (Davidson et al., 2011). Moreover, secondary infection 
induced the cardinal features of asthma, including airway hy-
perreactivity (AHR), airway remodeling (e.g., smooth muscle 
hyperplasia), and airway inflammation (Kaiko et al., 2013). 
Collectively, these findings suggest that the nexus between 
severe bronchiolitis and subsequent asthma is underpinned by 
perturbations to the pDC compartment (Lynch et al., 2014), 
although whether pDCs mediate protection via antiviral cy-
tokines, T reg cells, or both remains ill defined.
Here we used BDCA2-diptheria toxin receptor (DTR) 
transgenic mice (Swiecki et al., 2010) to induce the specific 
and temporal depletion of pDCs during primary PVM in-
fection alone. In neonatal, but not adult, mice, pDC deple-
tion increased bronchiolitis severity and was sufficient to 
evoke an asthma-like phenotype upon viral challenge. In 
adult mice, pDC depletion was insufficient to induce severe 
bronchiolitis, unless the microbiota was perturbed, suggesting 
that host–commensal interactions are protective. In both age 
groups, bronchiolitis was associated with a failure to expand 
neuropilin-1 (Nrp-1)+ T reg cells, caused by the absence of 
pDC-expressed semaphorin 4a (Sema4a). Supplementa-
tion of pDC-depleted neonates with the microbial metab-
olite propionate increased the number of Sema4a-expressing 
monocyte-derived DCs (moDCs), expanded Nrp-1+ T reg 
cells, and conferred protection against severe viral bronchiol-
itis and subsequent asthma. Sema4a blockade attenuated the 
protective effects of propionate, including the expansion of 
Nrp-1+ T reg cells, suggesting that pDCs and the microbiome 
confer resistance through a common pathway. Similarly, we 
found a propionatelow IL-10low IL-6high phenotype in 2-yr-old 
children with viral bronchiolitis. Together, our findings high-
light a common but age-related Sema4a-mediated pathway 
by which pDC and microbial colonization confer protection 
against severe bronchiolitis and subsequent asthma.
reSuLtS
pdc depletion predisposes toward severe PVM-induced 
bronchiolitis in neonatal but not adult mice
Several studies have implicated a key role for pDCs in con-
trolling the severity of RSV infection by using anti-BST2 
(also known as PDCA-1 or clone 120G8) to deplete pDCs 
(Smit et al., 2006; Wang et al., 2006). However, because type 
I and II IFNs up-regulate the expression of BST2 on other 
immune cells, this approach is potentially confounded. In 
contrast, the BDCA2-DTR transgenic mouse strain allows 
for the specific and inducible depletion of pDCs during the 
course of infection (Swiecki et al., 2010). To address the role 
of pDCs during acute respiratory viral infection in early life, 
we first sought to determine whether diphtheria toxin (DT) 
exposure would deplete pDCs in the lungs and mediastinal 
lymph nodes (MLN) of BDCA2-DTR neonates. To test this, 
6-d-old BDCA2-DTR transgene–positive (hereafter pDCΔ) 
and negative (WT) littermates were exposed to a single, 
low dose of DT (3,000 ng/kg body weight, i.p.), and pDCs 
(CD11b−, B220+, CD11c+, Siglec-H+, CD45RA+) were as-
sessed 24 h later by flow cytometry. Using this protocol, pDCs 
were >85% lower in pDCΔ neonates compared with their 
WT counterparts (Fig. S1 a). In contrast, lung myeloid DCs 
(MHC IIhi, CD11chi, CD11b+, B220−) were unaffected by 
DT treatment (not depicted). In line with previous studies 
(Swiecki et al., 2010), a dose of 6,000 ng/kg was required to 
deplete pDCs in the lungs and MLN of pDCΔ adult mice. 
To evaluate whether pDC depletion predisposes to severe 
viral bronchiolitis, and whether susceptibility was age-related, 
1- and 6-wk-old pDCΔ and WT littermates were inoculated 
with low-dose PVM (10 plaque-forming units [PFU], i.n.) 
or vehicle (10% FCS/DMEM), treated with DT (irrespec-
tive of genotype) at −1, 1, 3, and 5 d postinfection (dpi) and 
killed at 7 and 10 dpi (Fig. 1 a). Vehicle-inoculated mice were 
treated with DT and killed at 10 dpi. At 7 dpi, the peak of 
pDC infiltration to the PVM-infected lung (Davidson et al., 
2011; Kaiko et al., 2013; Edwards et al., 2015), pDCs were 
significantly lower in the lungs and MLN of pDCΔ neonates 
and pDCΔ adults (Fig. 1, b and c), but had recovered by 10 
dpi (Fig. S1 b). Consistent with a critical role for pDCs in the 
generation of innate antiviral cytokines during acute PVM 
infection in early life (Davidson et al., 2011; Kaiko et al., 
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Figure 1. pdc depletion predisposes toward severe PVM-induced bronchiolitis and subsequent asthma in neonatal but not adult mice. 
(a) Study design. 1-wk-old (neo) or 6-wk-old (adult) pDCΔ and WT mice were treated with DT (i.p. route, 15 ng) at −1, 1, 3, and 5 dpi, inoculated with PVM 
or vehicle at 0 dpi, and killed at 7 and 10 dpi. (b and c) pDC (CD11b− B220+ CD11c+ Siglec-H+ CD45RA+) number in lung (b) and MLNs (c). (d) IFN-α, IFN-λ, 
and IL-12p40 protein expression in BALF. (e) Representative micrograph (x1000 magnification) of PVM immunoreactivity in the airway epithelium, and 
quantification of PVM positive AECs. Bars, 50 µm. (f) Quantification of AEC sloughing. (g) Neutrophil and eosinophil numbers in BAL. (h) Proinflammatory 
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2013), IFNα and IFNλ levels in the bronchoalveolar lavage 
fluid (BALF) were >100-fold lower in both neonatal and adult 
pDCΔ mice compared with age-matched WT mice (Fig. 1 d 
and Fig. S1 c). As expected, pDC depletion increased the viral 
load in the airway epithelium, the primary site of Pneumo-
virus replication. In WT neonatal and adult mice, PVM G 
protein expression peaked at 7 dpi (Figs. 1 e and S1 d), then 
fell to fewer than 5% of airway epithelial cells (AECs) by 10 
dpi. In contrast, twice as many AECs were PVM positive in 
both pDCΔ neonates and adults at 7 dpi (Fig. 1 e and Fig. S1 
d). Moreover, both neonatal and adult pDCΔ mice exhibited 
a marked delay in viral clearance at 10 dpi.
AEC detachment is a feature of viral bronchiolitis and is 
associated with disease severity and viral load (Johnson et al., 
2007). In our model, AEC sloughing was significantly elevated 
in neonatal pDCΔ compared with WT mice, but was absent 
in adult pDCΔ and WT mice (Fig. 1 f and Fig. S1 e). Weight 
loss was similar between pDCΔ and WT adults, whereas pDCΔ 
neonates exhibited stunted weight gain compared with WT 
controls (not depicted), suggestive of a hyper-inflammatory 
response in the pDCΔ neonates. Indeed, airway neutrophilia 
and eosinophilia was evident in neonatal but not adult pDCΔ 
mice (Fig. 1 g and Fig. S1 f). The expression of IL-6 was ele-
vated at 10 dpi in both neonatal and adult pDCΔ mice relative 
to age-matched WT mice, whereas the levels of TNF-α, KC 
(CXCL1), and IFN-γ were significantly elevated in pDCΔ ne-
onates but not pDCΔ adult mice (Fig. 1 h and Fig. S1 g). Col-
lectively, these data suggest that pDCs are critical for antiviral 
cytokine production and viral control in both neonatal and 
adult mice, but only in the neonatal period are pDCs necessary 
to temper the magnitude of the inflammatory response.
Severe bronchiolitis is often associated with an elevated 
type 2 inflammatory response (Bendelja et al., 2000; Shep-
pard et al., 2003; Caballero et al., 2015). When compared with 
age-matched WT littermates, the levels of eotaxin-2 (CCL24), 
IL-5, IL-13, and IL-33 (but not IL-4, TSLP, or IL-25; not de-
picted) were significantly elevated at 10 dpi in neonatal, but 
not adult pDCΔ mice (Fig. 1 i and Fig. S1 h). The elevated 
expression of IL-5 and IL-13 but not IL-4 implicated a po-
tential role for type 2 innate lymphoid cells (ILC2s), and in-
deed ILC2 (Lineage− CD90.2+ CD25+ ST2+) numbers were 
significantly elevated in the lungs of pDCΔ neonates com-
pared with pDCΔ adult mice, WT neonates, and WT adults 
(Fig. 1 j and Fig. S1 i). To identify the cellular source of IL-13, 
we crossed pDCΔ mice with 4C13R reporter mice, which 
express AmCyan fluorescent protein under the control of 
the IL-4 promoter and dsRed fluorescent protein under the 
control of the IL-13 promoter (Huang et al., 2015). As with 
pDCΔ neonatal mice, double transgenic pDCΔ(4C13R) neona-
tal mice developed severe bronchiolitis (not depicted). In the 
lungs, we found that ILC2s, together with CD4+ Th2 cells 
and CD8+ Tc2 cells, were the major source of IL-13 in neo-
natal pDCΔ mice (Fig. 1 k). Total numbers of lung and MLN 
CD4 and CD8 T cells (Fig. S1 j) and the levels of IL-17A in 
BALF (Fig. 1 h and Fig. S1 k) were not significantly different 
between pDCΔ and WT at either age.
Severe bronchiolitis in early life predisposes to subsequent 
asthma upon viral challenge
The severity of RSV-bronchiolitis is a major independent risk 
factor for asthma (Feldman et al., 2015), and so we hypothesized 
that if RSV bronchiolitis were causal, pDC depletion in early 
life alone would be sufficient to predispose toward subsequent 
asthma in later life. To test this, mice that had experienced severe 
viral bronchiolitis (pDCΔ neonates) or had been asymptomatic 
(WT neonates) in early life were challenged with PVM at 7 
wk of age (Fig. 2 a). Noninfected vehicle groups for each gen-
otype served as controls. Consistent with our hypothesis, only 
mice that had experienced severe viral bronchiolitis (pDCΔ) 
in infancy exhibited airway resistance at 7 d after viral chal-
lenge (Fig. 2 b). When we examined the lungs for pathological 
features of asthma, again only the mice that had experienced 
severe viral bronchiolitis in early life developed the cardinal 
features of asthma, including airway smooth muscle (ASM) re-
modeling, mucus plugging, and type 2 inflammation (airway 
eosinophilia, type 2 cytokine expression (IL-4 and IL-13) and 
periostin deposition (Fig. 2, c and d; and Fig. S2, a–d). With the 
exception of AHR, all pathologies of asthma were present only 
after viral challenge (Fig. S1 e), and hence were not merely a 
consequence of the primary infection. Further, the asthma-like 
pathologies were not related to an altered type 1 or type 17 in-
flammatory response (Fig. S2, c and d), PVM-specific antibody 
levels (Fig. S2 f), or changes in lung pDC numbers during viral 
challenge (Fig. S2 g).
Using pDCΔ(4C13R) mice, we observed that CD4+ Th2 
cells were the dominant source of IL-13 in the lungs, although 
IL-13–producing CD8+ Tc2 cells were also significantly ele-
vated in the MLN of pDCΔ(4C13R) mice (Fig. S2  h). IL-4/
IL-13 expression was restricted to T lymphocytes, consistent 
with the absence of ILC2 expansion in the lungs at 1, 3, or 7 d 
after viral challenge (not depicted). Collectively, these results 
suggest that severe viral bronchiolitis in early life is causally 
linked to virus-provoked eosinophilic asthma in later life.
pdc support the expansion of nrp-1+ t reg cells and IL-10 
production in the lung during early-life PVM infection
pDCs have been reported to support T reg cells (de Heer et al., 
2004; Sharma et al., 2007; Palomares et al., 2012), and hence 
cytokine production in lung tissue. (i) Type-2 cytokine production in BALF. (j) Representative flow cytometry plots and number of type 2 ILCs in lung. 
Quadrants display percentage of parent population. (k) Representative flow cytometry plots and numbers of IL-13 (dsRed) and IL-4 (AmCyan) expressing 
type 2 ILCs, CD4+ and CD8+ T cells in lungs of WT/4C13R and pDCΔ/4C13R mice at 10 dpi. Data are representative of n = 2 experiments with 6–8 mice per 
group and presented as box-and-whisker plots showing quartiles (boxes) and range (whiskers). Data were analyzed using one-way ANO VA with Tukey’s post 
hoc test; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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we questioned whether severe bronchiolitis was a consequence 
of insufficient immunoregulation. Because the overexuberant 
inflammatory response peaked at 10 dpi (Fig. 1, g–i), we first 
quantified T reg cells in the lungs and MLNs at 5, 7, and 10 dpi. 
Probing the lungs with anti-FoxP3 by immunohistochemistry 
revealed that in WT mice, FoxP3+ cells were widely distributed 
and sparse in number at baseline, but rapidly increased at 7 dpi 
and persisted until at least 10 dpi. In contrast, there was a negligi-
ble increase in FoxP3+ cells in pDCΔ mice (Fig. 3 a). Using flow 
cytometry, we confirmed our immunohistochemical findings 
and identified that the vast majority (>80%) of the T reg cells 
(CD3+, CD4+, CD25+, FoxP3+) were positive for neuropilin-1 
(Nrp-1; Fig. 3 b) and Helios (not depicted), putative markers of 
thymic T reg cells (Weiss et al., 2012; Yadav et al., 2012). In the 
MLN, Nrp-1+ T reg cell expansion began at 5 dpi (2 d before 
their increase in the lung) and peaked at 7–10 dpi (Fig. 3 c): this 
response was significantly diminished in pDCΔ neonates. In con-
trast, the numbers of FoxP3− CD4+ conventional T cells (T con) 
and FoxP3− CD8 T con in the lung and MLN were unaltered 
by pDC depletion (Fig. S1 j). To assess Nrp-1+ T reg cell prolifer-
ation in the MLN in vivo, we injected the mice with BrdU. The 
frequency of BrdU+ T reg cells was significantly lower in pDCΔ 
compared with WT neonates, at both 7 and 10 dpi (Fig. 3 d). 
Notably, the failure to expand T reg cells in pDCΔ mice coin-
cided with the period pDCs would normally infiltrate the lungs 
and MLN (Fig. 3, e and f) and was not associated with altered 
Nrp1 expression (Fig. 3 b). The level of MHC-II expression on 
pDCs was increased in response to PVM infection (∼2-fold in 
the MLN and ∼5-fold in the lung; Fig. 3 g), although whether 
pDCs were actively presenting PVM antigens to the T reg cells 
remains to be demonstrated.
The levels of IL-10, an immunoregulatory cytokine se-
creted by T reg cells, was elevated in the lungs of infected WT 
mice but not pDCΔ neonates (Fig.  3  h). Double transgenic 
pDCΔ/IL-10-GFP+ mice revealed that pDC depletion primar-
ily affected T reg cell and CD4+ T con cell IL-10 production 
(Fig. 3 h). The expression of active TGF-β1, another immuno-
regulatory cytokine, was similarly diminished at 10 dpi in pDCΔ 
neonates but not at earlier time points (not depicted). Moreover, 
examination of several functional surface markers on T reg cells 
revealed that the nucleotidase CD39 was markedly lower on lung 
Nrp-1+ T reg cells from pDCΔ neonates compared with their 
WT counterparts (Fig. 3 i). Collectively, our data indicate that 
pDCs contribute to the expansion and functional maturation of 
Nrp-1+ T reg cells during Pneumovirus infection in early life.
pdc expression of Sema4a expands nrp-1+ t reg cells 
during early-life PVM infection
To address whether pDCs directly support T reg cell expan-
sion, pDCs were purified from the MLN of WT neonates and 
co-cultured at a 1:40 ratio with CFSE-labeled CD4+ T cells 
purified from the MLN of pDCΔ(4xDT) neonates (Fig.  4  a). 
In the absence of pDCs, stimulation with α-CD3 alone did 
not increase the level of T reg proliferation, as measured by 
Figure 2. Severe bronchiolitis in early life 
predisposes to subsequent asthma. (a) Study 
design. 1-wk-old (neo) or 6-wk-old (adult) 
pDCΔ and WT mice were treated with DT (i.p. 
route, 15 ng) at −1, 1, 3, and 5 dpi, inoculated 
with PVM or vehicle at 0 dpi, challenged with 
PVM at 42 dpi, and killed at 49 dpi. (b) AHR. 
(c) ASM area. Representative micrographs of 
ASM (400× magnification); arrows indicate 
ASM (pink). Bars, 50 µm. (d) Airway intralumi-
nal mucus plugging. (e) Eosinophils in BAL. (f) 
IL-13 protein expression in BALF. Data are rep-
resentative of n = 2 experiments with five to 
six neonates in each group and are presented 
as mean ± SEM (b) or box-and-whisker plots 
showing quartiles (boxes) and range (whiskers; 
c–f). Data were analyzed by two-way ANO VA 
(b) or one-way ANO VA (c–f) with Tukey’s post 
hoc test; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 3. pdc depletion diminishes the expansion of nrp-1+ t reg cells and IL-10 production in the lung during early-life PVM infection. 
(a) FoxP3+ cells enumerated in lung tissue sections. (b) Histogram of Nrp-1 expression on T reg cells (gated on CD4+ CD3ε+ CD25+ CD25+ Foxp3+; top) 
and number of Nrp-1+ T reg cells in lung (bottom). (c) Number of Nrp-1+ T reg cells in MLN. (d) Representative flow cytometry plots of BrdU expression 
by Nrp1+ T reg cells in MLN. (e and f) Proliferating BrdU/Nrp-1+ T reg cells in MLN. Kinetics of pDC number in lung (e) and MLN (f). (g) MHC II expression 
on pDCs. (h) IL-10 protein expression in lung (left) and IL-10-GFP+ cells in lung (middle) and MLN (right). (i) Immune-suppressive expression on Nrp-1+ 
T reg cells in lung. Data are representative of n = 2 experiments with four to six neonates in each group and are presented as mean ± SEM (a–c and f) or as 
box-and-whisker plots showing quartiles (boxes) and range (whiskers; d, f, and g). Data were analyzed by one-way ANO VA with Tukey post hoc test (a–f and 
h) or Mann–Whitney U test (g, h [right], and i); *, P < 0.05; **, P < 0.01; ***, P < 0.001 compared with the WT control group.
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a decrease in CFSE intensity, compared with the unstim-
ulated cells (Fig.  4  b). When stimulated in the presence of 
pDCs from PVM-infected but not naive WT mice, there was 
a significant increase in FoxP3+ Nrp1+ T reg cell prolifer-
ation. Blockade with anti-Sema4a significantly reduced this 
response (Fig. 4 b), suggesting that pDCs provide the cog-
nate ligand for Nrp-1, recently identified as Sema4a (Del-
goffe et al., 2013). Strikingly, surface expression of Sema4a 
was markedly higher on pDCs compared with other anti-
gen-presenting cells in the MLN (Fig. 4 c), the site of T reg 
cell expansion (Fig. 3, c and d), and was increased after PVM 
infection (Fig. 4 d). Notably, other prototypical APCs, includ-
ing conventional DCs (cDCs), moDCs, and alveolar macro-
phages sourced from infected pDC-depleted neonates, were 
insufficient to induce T reg cell proliferation (Fig. 4 e).
Blockade of Sema4a but not IFnαr1 signaling increases 
bronchiolitis severity and predisposes to subsequent asthma
To specifically address whether pDCs protect against severe 
viral bronchiolitis via the production of antiviral cytokines 
or the expansion of T reg cells, we treated PVM-infected 
WT neonates with anti-Sema4a or anti-IFNαR to block 
Sema4a-Nrp-1 or type I IFN signaling, respectively 
(Fig.  5  a). As expected, anti-IFNαR but not anti-Sema4a 
diminished IFN-α expression and increased viral burden 
(Fig.  5, b and c), while not affecting pDC numbers (not 
depicted). In contrast, Sema4a, but not IFN-αR, blockade 
significantly decreased T reg cell numbers, proliferation, and 
CD39 expression, as well as IL-10 levels in the lung (Fig. 5, 
d–f). Critically, perturbing the T reg cell response but not 
type I IFN signaling led to increased AEC sloughing, granu-
locytic inflammation, and type 2 inflammation (Fig. 5, g–j), 
suggesting that Sema4a blockade in early life may be suf-
ficient to predispose toward asthma in later life. To assess 
this, we repeated the early-life treatment with anti-Sema4a 
during primary infection and then challenged with PVM 
6 wk later. Similar to pDC depletion, Sema4a blockade in 
early life alone was sufficient to induce the hallmark fea-
tures of asthma in later life (Fig. 5, k–o). Collectively, these 
findings suggested that a failure to generate Nrp-1+ T reg 
Figure 4. pdc expression of Sema4a expands nrp-
1+ t reg cells during early-life PVM infection. 
(a) Protocol for APC and CD4+ T cell co-culture. (b and e) 
Mean fluorescence intensity of CFSE in Nrp1+ T reg cells. 
(c) Sema4a expression on MLN APCs at 7 dpi. (d) Sema4a 
expression on MLN pDCs. For panels b and e, each data 
point represents a technical replicate and is representa-
tive of n = 2 independent experiments. For panels c and d, 
data are representative of n = 2 independent experiments 
with four to six neonates in each group and are presented 
as box-and-whisker plots showing quartiles (boxes) and 
range (whiskers). Data were analyzed by one-way ANO VA 
with Tukey post hoc test (b, c, and e) or Mann–Whitney 
U test (d); #, P < 0.05; **, P < 0.01; ***, P < 0.001 com-
pared with unstimulated cells (b and e), pDCs (c), naive 
group (d), or as indicated.
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cells in early life predisposes toward both severe bronchiol-
itis and subsequent asthma.
nrp-1+ t reg cell transfer prevents the development of 
PVM-induced bronchiolitis and subsequent asthma
To confirm the importance of T reg cells, we next isolated 
Nrp-1+CD4+FoxP3+ T reg or T con (CD4+FoxP3−) cells 
from the MLN of PVM-infected FoxP3-RFP mice and 
adoptively transferred 30,000 cells (i.p. route) to pDCΔ ne-
onates at 5 dpi (Fig. 6 a), simulating the time of T reg ex-
pansion (Fig. 3 c). The transfer of T reg but not T con cells 
significantly decreased AEC sloughing, IL-6 production, 
granulocytic inflammation, IL-13 and IL-33 levels, and nu-
clear-to-cytoplasmic translocation of HMBG1 in AECs in 
early life (Fig. 6, b–h). Of note, neither T reg nor T con cell 
transfer affected viral load (Fig. 6 i). Consistent with a causal 
role for RSV-bronchiolitis in the onset of postviral asthma 
in later life, the restoration of Nrp-1+ T reg cells in early 
life was sufficient to protect against viral challenge–induced 
asthma (Fig. 6, j–m). Antigen-specific T reg cells are superior 
Figure 5. Blockade of Sema4a but not IFnαr1 signaling increases bronchiolitis severity and predisposes to subsequent asthma. (a) Protocol of 
PVM inoculation and administration of αSema4a or isotype control (IgG2a) and αIFNαR or isotype control (IgG1) to neonatal WT mice. (b) IFN-α protein 
expression in BALF, expressed as % change of the respective isotype control. (c) Viral load in the airway epithelium. (d) Nrp-1+ T reg cells in the lung. 
(e) IL-10 protein expression in lung, expressed as % change of the respective isotype control. (f) CD39 expression by Nrp-1+ T reg cells. (g) Sloughing of the 
airway epithelium. (h) Eosinophil number in BAL. (i) IL-33 protein expression in lung, expressed as % change of the respective isotype control. (j) Type-2 
ILCs in lung. (k) AHR. (l) ASM area. (m) Intraluminal mucus plugging. (n) Eosinophil number in BAL. (o) IL-13 protein expression in BAL. Data are represen-
tative of n = 2 experiments with four to six neonates in each group and are presented as the mean ± SEM (k) or box-and-whisker plots showing quartiles 
(boxes) and range (whiskers; b–o). Data were analyzed by one-way (b–j and l–o) or two-way (k) ANO VA with Tukey’s post hoc test; *, P < 0.05; **, P < 0.01 
compared with the respective isotype control–treated group or as indicated.
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Figure 6. nrp-1+ t reg cell restoration prevents the development of PVM-induced bronchiolitis. (a) Protocol of acute PVM infection/pDC depletion 
and Nrp-1+ T reg adoptive transfer 5 dpi (30,000 Nrp-1/Foxp3-RFP+ T reg cells, Foxp3-RFP− T con or vehicle diluent; intranasal route). (b and n) Sloughing 
of the airway epithelium. (c) IL-6 protein expression in the lung. (d and o) Neutrophil number in BAL. (e, l, and p) Eosinophil number in BAL. (g) IL-33 
expression in BALF. (h) Nuclear to cytoplasmic HMGB1 translocation in AECs. (f and m) IL-13 expression in BALF. (i) Viral load in the airway epithelium. 
(j) AHR. (k) ASM area. Data are representative of n = 2 experiments with four to six neonates in each group and are presented as the mean ± SEM (j) or 
box-and-whisker plots showing quartiles (boxes) and range (whiskers; b–i and k–p). Data were analyzed by one-way (b–i and k–p) or two-way (j) ANO VA 
with Tukey’s post hoc test; *, P < 0.05; **, P < 0.01; ***, P < 0.001 compared with WT mice or as indicated; #, P < 0.05; ##, P < 0.01 compared with pDCΔ mice.
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to polyclonal T reg cells in their suppressor capacity (Tarbell 
et al., 2007). Hence, in an attempt to address antigen speci-
ficity of the Nrp1+ T reg cells, we next assessed the efficacy 
of splenic T reg cells. Unlike the T reg cells isolated from the 
MLN, the adoptive transfer of 30,000 splenic Nrp1+ T reg 
cells from PVM-infected neonatal mice was not sufficient to 
confer protection (Fig. 6, n–p). However, consistent with the 
ability of T reg cells to suppress inflammation in a nonspecific 
manner, the transfer of 300,000 cells did ameliorate disease 
severity in pDCΔ neonates (Fig. 6, n–p).
Microbial colonization in adult mice confers 
resistance to viral bronchiolitis
The fundamental role of T reg cells in protecting against se-
vere RSV-bronchiolitis in infants (Figs. 3 and 4), together 
with the age-dependent nature of disease susceptibility 
(Fig. 1), suggested that in adult mice, the expansion of T reg 
cells is less dependent on pDCs. Consistent with this notion, 
PVM infection of adult pDCΔ mice had no effect on the 
numbers of Nrp-1+ T reg cells in the lungs or MLN, nor 
did it effect their expression of CD39 (Fig. 7, a–c) or Nrp1 
(not depicted). Recent insights have revealed that microbial 
metabolites, such as the short-chain fatty acids (SCFAs) pro-
panoic acid, acetic acid, and butyric acid, shape host immu-
nity by promoting the differentiation of T reg cells (Arpaia 
et al., 2013; Furusawa et al., 2013). This led us to hypothesize 
that the postnatal assembly of the microbiota, which is com-
plete by 6 wk of age in mice (Pantoja-Feliciano et al., 2013; 
Gollwitzer et al., 2014), may confer protection in older mice 
through the expansion of T reg cells. As expected, the levels 
of SCFAs propanoic acid, acetic acid, and butyric acid were 
significantly greater in adults compared with neonatal mice 
in both fecal pellets and serum, with the exception of serum 
butyrate levels (Fig.  7  d). The gut microbiota of WT and 
pDCΔ neonates was similar: both were dominated by bacteria 
affiliated with the Firmicutes (Lactobacillus spp.), Bacteroi-
detes (Bacteroidales S24-7, Bacteroides spp. and Parabacte-
roides spp.), and Verrucomicrobia (Akkermansia spp.; Fig. 7 e 
and Fig. S3 a). The gut microbiota of WT and pDCΔ adult 
mice was also similar, and although bacteria affiliated with 
the Firmicutes (Lactobacillus spp. and Allobaculum spp.) and 
Bacteroidetes (Bacteroidales S24-7) were again dominant, 
there was a reduction in bacteria affiliated with the Verru-
comicrobia (Akkermansia spp.) and an increase in bacteria 
affiliated with the Actinobacteria (Bifidobacterium spp. and 
Adlercreutzia spp.) compared with neonatal mice (Fig. 7 e 
and Fig. S3 a). Treatment of pDCΔ and WT adult littermates 
with broad-spectrum antibiotics (ABX; vancomycin, neo-
mycin, ampicillin, metronidazole) for 6 wk (Russell et al., 
2012; Moon et al., 2015) led to a dramatic and similar reduc-
tion in diversity, and to a community dominated by bacteria 
affiliated with Parabacteroides spp. (Fig. 7 e). Moreover, the 
levels of propanoic acid, acetic acid, and butyric acid in the 
fecal pellets in mice of both genotypes and serum propanoic 
acid in pDCΔ mice were significantly decreased (Fig. 7 f and 
Fig. S3 a). Notably, ABX treatment of pDCΔ mice, but not 
WT mice, significantly attenuated the expansion of T reg 
cells in the lungs and MLN, as well as their expression of 
CD39 (Fig. 7, a–c), leading to a marked increase in weight 
loss, AEC sloughing, and eosinophilic inflammation, without 
affecting viral burden (Fig. 7, g–k).
nasal ScFA propanoic acid levels inversely correlate with a 
proinflammatory milieu in human viral bronchiolitis
We next explored whether our findings were relevant to 
human disease by analyzing samples from children recruited 
as part of an influenza vaccine effectiveness study (Table S1). 
Of those with viral bronchiolitis, 10 of 20 subjects were pos-
itive for RSV. In the absence of fecal or serum samples, we 
compared SCFAs and cytokine levels in the nasal secretions 
of infants with viral or nonviral bronchiolitis. Strikingly, the 
levels of SCFA propanoic acid were significantly lower in in-
fants with viral bronchiolitis compared with nonviral bron-
chiolitis (Fig.  7  l). In contrast, the levels of acetic acid and 
butyric acid did not differ between the groups (Fig. 7 m and 
Fig. S3, b and c). In the children with viral (but not nonviral) 
bronchiolitis, expression of proinflammatory IL-6 was signifi-
cantly increased in the nasal secretions (Fig. 7 n). Although 
the expression of anti-inflammatory IL-10 was not different 
(Fig. 7 o), we found that propanoic acid levels negatively cor-
related with the expression of IL-6 and positively correlated 
with anti-inflammatory IL-10 (Fig. 7 p and Fig. S3 c).
exogenous ScFA propionate confers protection 
against severe bronchiolitis and subsequent asthma in 
pdc-depleted neonatal mice
Our findings suggested that the lower levels of SCFAs in 
neonatal pDCΔ mice contribute to the age-dependent sus-
Figure 7. Microbial colonization in adult mice confers resistance to viral bronchiolitis. (a–c) Nrp-1+ T reg cell number in lung (a) and MLN (b) and 
CD39 expression (c). (d) SCFA levels in feces (left) and serum (right) of neonatal and adult WT mice. (e) Relative abundance of bacterial phyla. (f) SCFA 
levels in WT and pDCΔ mice treated with broad-spectrum ABX or vehicle. (g) Weight loss over the course of PVM infection. (h) Airway epithelium sloughing. 
(i) Neutrophil number in BAL. (j) Eosinophil number in BAL. (k) Viral load in the airway epithelium. (l) Propanoic acid levels in the nasal secretions of 
human subjects with nonviral (n = 10) or viral (n = 20) bronchiolitis. (m) Acetic acid levels in the nasal secretions. (n) IL-6 expression in the nasal secretions. 
(o) IL-10 expression in the nasal secretions. (p) Correlations between SCFA propanoic acid and IL-6 (left) and IL-10 (right) in infants with viral bronchiolitis. 
Data are representative of n = 2 experiments with four to six mice in each group and presented as box-and-whisker plots showing quartiles (boxes) and 
range (whiskers; a–d, f, h–k) or mean ± SEM (i–o) or as individual subjects (p). Data were analyzed by one-way (a–c and h–k) or two-way (g) ANO VA with 
Tukey’s post hoc test or Mann–Whitney U test (d and l) or Spearman’s rank-order correlation (p); *, P < 0.05; **, P < 0.01; ***, P < 0.001 compared with 
neonatal mice, without ABX WT mice, or as indicated. See also Table S1.
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ceptibility to severe bronchiolitis. To test this, we added 
SCFA propionate to the drinking water of pregnant dams 
and administered SCFA propionate i.p. to the pups (Fig. 
S3 d). This regimen led to serum propanoic acid levels that 
were comparable to adult mice (Fig. S3 e). Strikingly, the 
attenuated expansion of T reg cells in pDCΔ neonates was 
completely restored by SCFA propionate supplementa-
tion (Fig. 8  a), which in turn ablated AEC sloughing and 
neutrophilic inflammation (Fig. 8, b and c), and protected 
against the development of type 2 inflammation (Fig. 8, d 
and e). Notably, these effects occurred independently of 
an alteration to IFN-α production (Fig. S3 f) or the num-
ber of pDCs (Fig. S3  g). Critically, treatment with SCFA 
propionate in early life alone was sufficient to prevent the 
development of virus-induced ASM remodeling, type 2 in-
flammation, and AHR in later life (Fig. 8, f–i).
ScFA propionate confers protection through a 
Sema4a-dependent mechanism
SCFAs promote colonic T reg cell differentiation both di-
rectly, by affecting the stability of FoxP3 (Tao et al., 2007; 
Arpaia et al., 2013; Furusawa et al., 2013), and indirectly, by 
affecting the function of DCs (Arpaia et al., 2013; Trom-
pette et al., 2014). To assess whether the protective effect of 
SCFA propionate on pDC-depleted mice might be medi-
ated through enhanced Sema4a-Nrp-1 signaling via an APC 
other than pDCs, we measured Sema4a mRNA in the lungs 
and observed a massive increase in both WT and pDCΔ ne-
onates after exposure to SCFA propionate (Fig. 9 a). Using 
flow cytometry, we identified that SCFA propionate ex-
clusively increased the numbers of Sema4a+ moDCs in the 
lungs and MLN of pDCΔ mice and the MLN of WT mice 
(Fig.  9  b). Strikingly, when stimulated in the presence of 
moDCs from PVM-infected, but not naive, WT mice, there 
was a significant increase in T reg cell proliferation (Fig. 9 c). 
Blockade with anti-Sema4a significantly reduced this re-
sponse, although the magnitude of the decrease was mod-
est. To ascertain whether the protective effect of propionate 
was mediated via the provision of Sema4a, we next treated 
pDCΔ mice with exogenous propionate in the presence of 
anti-Sema4a. Although anti-Sema4a did not affect the pro-
pionate-mediated increase in Sema4a+ moDCs in the lung 
or MLN as expected (Fig. 10, a and b), it significantly de-
creased the expansion of T reg cells and abrogated the ben-
eficial effects of propionate on CD39 expression (Fig. 10, b 
and c). Furthermore, perturbing the restoration of the T reg 
cell response led to an increase in AEC sloughing, granulo-
cytic inflammation, and type 2 inflammation (Fig. 10, d–h) 
and predisposed toward virus-induced asthma (Fig. 10, i–l), 
consistent with an important role for Sema4a and down-
stream T reg cell expansion in conferring protection against 
severe bronchiolitis and subsequent asthma.
dIScuSSIon
Severe RSV-bronchiolitis in infancy is a major risk factor 
for subsequent asthma; however, the immunological mech-
Figure 8. exogenous ScFA propio-
nate confers protection against severe 
bronchiolitis and subsequent asthma in 
pdc-depleted neonatal mice through a 
Sema4a-dependent mechanism. (a) Nrp-1+ 
T reg cells in lung and MLN. (b) Airway epi-
thelium sloughing. (c and d) Neutrophil (c) 
and eosinophil (d) numbers in BAL. (e) Type-2 
ILCs in the lung. (f) ASM area. (g) Intralumi-
nal mucus plugging. (h) Eosinophil number 
in BAL. (i) AHR. Data are representative of 
n = 2 experiments with four to six neonates 
in each group and presented as the mean ± 
SEM (i) or box-and-whisker plots showing 
quartiles (boxes) and range (whiskers; a–h). 
Data were analyzed by one-way (a–h) or 
two-way (i) ANO VA with Tukey’s post hoc test; 
*, P < 0.05; **, P < 0.01 compared with vehi-
cle-treated WT mice; #, P < 0.05; ##, P < 0.01; 
###, P < 0.001 compared with vehicle-treated 
pDCΔ mice. See also Fig. S3.
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anisms that underlie this association have remained elusive. 
Here we found that targeted pDC depletion during pri-
mary viral infection in infancy alone was sufficient to pre-
dispose to both severe bronchiolitis in early life and viral 
challenge–induced asthma in later life, suggesting causality. 
Consequent to pDC depletion, disease susceptibility was 
unrelated to the impaired antiviral IFN response; instead, 
it was underpinned by a failure to expand Nrp-1+ T reg 
cells, which were required to limit immunopathology and 
the onset of type 2 inflammation. Moreover, we identified 
that the age-dependent susceptibility to viral bronchiol-
itis was related to microbial colonization: elevated levels 
of the microbial SCFAs in older mice facilitated the ex-
pansion of lung T reg cells, thus providing a redundant 
pathway in the absence of pDCs. Strikingly, SCFA pro-
panoic acid levels were lower in the nasal secretions of 
young children with acute viral bronchiolitis compared 
with control subjects and inversely correlated with lev-
els of immunoregulatory IL-10. Our findings implicate 
a causal role for RSV-bronchiolitis in asthma onset and 
highlight a new molecular pathway by which both mi-
crobial colonization and optimal pDC function support 
Figure 9. Proprionate supplementation increases lung Sema4+ modcs. (a) Sema4a mRNA expression in lung. (b) Sema4a-expressing DC numbers 
in lung (top) and MLN (bottom). Nrp-1+ T reg cell number in lung. (c) Mean fluorescence intensity of CFSE in Nrp1+ T reg cells. For panels a and b, data are 
representative of n = 2 experiments with four to six neonates in each group and are presented as box-and-whisker plots showing quartiles (boxes) and 
range (whiskers). For panel c, each data point represents a technical replicate and is representative of n = 2 experiments. Data were analyzed by one-way 
ANO VA with Tukey’s post hoc test; *, P < 0.05; **, P < 0.01; ***, P < 0.001 compared with vehicle-treated pDCΔ mice (a and b) or unstimulated cells (c).
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T reg cell expansion to confer resistance against severe 
RSV-bronchiolitis and subsequent asthma.
pDCs are able to produce considerable quantities of 
type I IFNs. Impaired antiviral immunity, particularly defec-
tive type I IFN production, has been linked to asthma patho-
genesis, and low numbers of circulating pDCs in infancy are 
predictive of lower respiratory tract infections, wheezing, and 
asthma (Silver et al., 2009; Upham et al., 2009). In the pres-
ent study, we found that whereas pDC depletion in neonatal 
mice diminished the production of IFNα/λ and increased 
viral load, blockade of the type I IFN receptor was not suffi-
cient to cause AEC sloughing, which was routinely associated 
with severe neutrophilia. Rather, the increase in disease sever-
ity in pDC-depleted or anti-Sema4a–treated mice stemmed 
from a failure to support T reg cell expansion and the conse-
quent loss of IL-10– and TGF-β−mediated immunoregula-
tion. Critically, at the time of T reg cell expansion, the MLN 
were enriched with pDCs, and although other APCs also ex-
pressed Sema4a, it was most abundantly expressed on pDCs. 
Consistent with an important role for pDC-derived Sema4a, 
the aberrant T reg cell response was restricted to T reg cells 
expressing its cognate ligand, Nrp-1+. Using an in vitro sys-
tem, we demonstrated that pDCs directly mediated T reg cell 
expansion via Sema4a; in contrast, the other APC populations 
Figure 10. Propionate supplementation confers protection via Sema4a. (a and b) Sema4a-expressing moDC number in lung (a) and MLN (b). 
(c) Nrp1+ T reg cells in lung. (d) CD39 expression on Nrp1+ T reg cells in lung. (e) AEC sloughing. (f) Neutrophils in BALF. (g and i) Eosinophils in BALF. 
(h) ILC2s in lung. (j) Mucous production by AECs. (k) ASM growth. (l) AHR. Data are representative of n = 2 experiments with four to six neonates in 
each group and are presented as the mean ± SEM (l) or box-and-whisker plots showing quartiles (boxes) and range (whiskers; a–k). Data were analyzed by 
one-way (a–k) or two-way (l) ANO VA with Tukey’s post hoc test *, P < 0.05; **, P < 0.01; ***, P < 0.001 compared with vehicle-treated pDCΔ mice; #, P < 0.05; 
##, P < 0.01; ###, P < 0.001 compared with vehicle-treated pDCΔ mice; +, P < 0.05; ++, P < 0.01 compared with propionate-treated pDCΔ mice.
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that we tested did not promote T reg cell proliferation. We 
found that pDCs up-regulated MHC II, and that pDCs from 
infected and not naive mice promoted T reg cell prolifer-
ation in vitro. However, as our in vitro assay used agonistic 
anti-CD3, further studies are required to definitively demon-
strate whether pDCs present specific antigen or merely serve 
as a nonspecific accessory cell by providing Sema4a and other 
cofactors to expand virus-specific T reg cells in this model. 
We identified that pDCs are necessary for optimal T reg cell 
function: both IL-10 production and CD39 expression were 
diminished in pDC-depleted mice, consistent with previous 
research demonstrating that Sema4a-Nrp1 signaling pro-
motes the suppressive activity of T reg cells (Delgoffe et al., 
2013). Notably, the failure to induce the expansion of fully 
functional Nrp-1+ T reg cells led to an elevated type 2 re-
sponse; conversely, the adoptive transfer of competent Nrp-1+ 
T reg cells from infected WT mice attenuated bronchiolitis 
and suppressed type 2 inflammation and, moreover, prevented 
subsequent asthma in later life. Importantly, low T reg cell 
numbers are associated with RSV-bronchiolitis in infants 
(Raiden et al., 2014; Christiaansen et al., 2016), and although 
others have observed that T reg cells limit RSV-bronchiolitis 
in mice, our findings are the first to provide a cellular and 
molecular mechanism governing their expansion and activa-
tion. T reg cells have been shown to be aberrant in asthma; 
hence, future studies should address whether perturbations to 
pDC function contribute to the development of long-lived, 
dysfunctional T reg cells.
Infants are at greatest risk of severe RSV-associated 
morbidity and mortality (Nair et al., 2010), and in accordance 
with this, we found that pDC depletion in neonatal but not 
adult mice predisposed to severe bronchiolitis. In adult mice, 
pDC depletion attenuated innate antiviral immunity but did 
not ablate T reg cell expansion, suggesting the existence of 
a redundant pathway that develops with age. This led us to 
question whether the gut microbiota as the primary producer 
of SCFAs might drive this expansion. Consistent with the 
greater diversity of the gut microbiota, the levels of propa-
noic acid were several logs higher in the feces and serum 
of adult mice. To assess whether microbial colonization con-
ferred protection, we treated mice with ABX during rear-
ing, and although this decreased gut microbiota diversity and 
propanoic acid levels in both the feces and serum, it was only 
in conjunction with pDC depletion that the adult mice de-
veloped severe bronchiolitis. Notably, this phenotype was as-
sociated with a failure to expand Nrp-1+ T reg cells, as had 
occurred in neonatal mice, suggesting that pDCs and SCFAs 
act through a common pathway. Our data suggest that in neo-
natal immunity, pDCs play a critical role in supporting T reg 
cell development until the nascent microbiota is assembled 
and able to support T reg cell differentiation through the pro-
duction of metabolites such as SCFAs.
Strikingly, we found that propanoic acid levels were 
significantly lower in nasal secretions collected from 
2-yr-old children with viral bronchiolitis. Moreover, these 
levels correlated with a pathogenic IL-6hi, IL-10lo cytokine 
microenvironment. A limitation of our study is that we did 
not have access to fecal or serum samples, and so it was not 
possible to discern whether the low levels of SCFA pro-
pionate stemmed from local alterations to the respiratory 
microbiota (Teo et al., 2015; Mansbach et al., 2016) or was 
reflective of intestinal dysbiosis. Notably, the latter can af-
fect circulating SCFA levels, thereby influencing peripheral 
tissues such as the upper airways (Trompette et al., 2014). 
Furthermore, it remains unclear whether the low propio-
nate levels in the RSV-infected infants was a cause or conse-
quence of severe viral bronchiolitis; this question will need 
to be explored via a large prospective study. Nonetheless, 
our findings from the preclinical model suggest that strate-
gies aimed at modulating or mimicking the microbiota will 
diminish the substantial mortality and morbidity caused by 
RSV. In a recent population study, it was estimated that se-
vere RSV bronchiolitis causes ∼13% of asthma cases, which 
is notable because in our model protection against severe 
viral bronchiolitis with exogenous SCFA propionate served 
as an effective preventive treatment against the inception 
of asthma. Mechanistically, we observed that SCFA propio-
nate was able to replace pDC-mediated support of Nrp-1+ 
T reg cells by increasing the number of Sema4a-expressing 
moDCs in the lungs and MLN, potentially as a consequence 
of increased hematopoiesis in the bone marrow (Trompette 
et al., 2014). Notably, we found that Sema4a blockade ab-
lated the protective effects of SCFA against bronchiolitis and 
subsequent asthma, and thus we identify a common pathway 
through which microbial-derived metabolites and pDCs 
mediate the expansion of T reg cells.
In developed nations, microbial dysbiosis is increas-
ing because of changes in diet (i.e., a shift to higher fat/
sugar and lower fiber content), increased sanitation, for-
mula feeding, urban living, and other factors (Arrieta et al., 
2015). In a recent study, lower intestinal microbial diversity 
in the first 1 mo of life was observed in children who de-
velop asthma compared with healthy controls, and another 
reported lower abundance of distinct bacterial genera and 
alterations to fecal SCFA levels and other microbial metab-
olites at 3 mo of age (Abrahamsson et al., 2014; Arrieta et al., 
2015). A picture is also emerging to suggest that the respi-
ratory microbiome in early life impacts on severity of RSV 
bronchiolitis, recurrent wheezing and the development of 
asthma (Rosas-Salazar et al., 2016; Zhou et al., 2016), al-
though none of these studies has yet interrogated whether 
such changes affect T reg cell differentiation. In mice, sev-
eral investigators have shown that acute allergen-induced 
asthma is increased in germ-free or ABX-treated adult 
mice (Herbst et al., 2011; Hill et al., 2012; Russell et al., 
2012), and neonatal mice are similarly predisposed to al-
lergen-induced airway inflammation, as the core phyla are 
not established until 1 mo of life (Marsland and Gollwitzer, 
2014; Trompette et al., 2014). Adult mice fed a low-fiber 
diet also exhibit exaggerated type 2 allergic responses be-
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cause of an attenuated metabolome (Gollwitzer et al., 
2014). Our study is the first to implicate an important role 
of the microbiome in protecting against viral bronchiolitis 
and the later inception of asthma.
In summary, we identified that in neonatal WT mice, 
pDCs are necessary to confer protection against severe bron-
chiolitis and subsequent asthma, and that this dependence is 
lost upon microbial acquisition in later life. SCFA propionate 
supplementation to pDC-depleted neonatal mice promoted 
the immigration of moDCs to the lung, refurbishing the Se-
ma4a signal and restoring the Nrp-1+ T reg cell response, and 
hence conferred protection against severe viral bronchiolitis 
and subsequent asthma. Strategies that favorably affect the ac-
quisition of a diverse microbiota in early life, or supplemen-
tation with key microbial metabolites, are likely to be useful 




C57BL/6 BDCA-2-DTR male mice (provided by M. Col-
onna, Washington School of Medicine, St. Louis, MO) were 
time mated with WT (Animal Resources Centre), C57BL/6 
FoxP3-RFP (provided by C. Engwerda, QIMR Berghofer 
Medical Research Institute, Brisbane, QLD, Australia; Lin et 
al., 2005), C57BL/6 IL-10-GFP (Kamanaka et al., 2006), or 
C57BL/6 4C13R (Huang et al., 2015) females under spe-
cific pathogen–free conditions at the Australian Institute of 
Biotechnology and Nanotechnology Animal Facility. Neo-
natal mice were genotyped by standard PCR using primers 
against hGH (BDAC-2-DTR mice), forward 5′-GCC CCC 
GGG CAG CAC AGC CAC TGC CGG TCC-3′ and reverse 
5′-GGC CAA GCG CTT GGG CAC TGT TCC CTC CCT-3′; 
Dsred (4C13R mice), forward 5′-GCT CCA AGG TGT ACG 
TGA AG-3′ and reverse 5′-GCT TGG AGT CCA CGT AGT 
AG-3′; IL-10–GFP, mutant 5′-CCA AAA GAC GGC AAT 
ATG GT-3′, common 5′-GTG TGT ATT GAG TCT GCT 
GGAC-3′, and WT 5′-GTG TGG CCA GCC TTA GAA TAG-
3′; FoxP3-RFP mice, mutant 5′-GGA ATG CTC GTC AAG 
AAG ACA GG-3′, common 5′-CAA AAC CAA GAA AAG 
GTG GGC-3′, and WT 5′-CAG TGC TGT TGC TGT GTA 
AGG GTC-3′. All experiments were approved by the Uni-
versity of Queensland Animal Ethics Committee.
PVM inoculation
Pneumonia virus of mouse stock J3666 was prepared as pre-
viously described (Davidson et al., 2011). 10 PFU PVM or 
vehicle diluent (DMEM/FBS, 10% vol/vol; Gibco) was ad-
ministered i.n. on day 7 or 49 of life under light isoflurane-in-
duced anesthesia. In some experiments, mice were reinfected 
with 100 PFU PVM on day 49 of life.
Mouse treatments
BDCA2-DTR transgene–positive (denoted pDCΔ) and 
–negative (denoted WT) littermates received a low dose (ne-
onates, 3,000 ng/kg; adults, 6,000 ng/kg) DT (Calbiochem) 
by i.p. injection at −1, 1, 3, and 5 dpi. DT administration 
with these protocols did not induce any adverse effects or an 
immune response in the absence of infection. A concentrated 
aqueous solution of BrdU (10:1; Invitrogen) was administered 
i.p. at 3, 5, 7, 8, and 9 dpi. 10 µg α-Sema4a (clone 757129; 
R&D Systems) or isotype control (IgG2a; R&D Systems) and 
50 µg αIFNαR or isotype control (IgG1) were administered 
i.p. at 3, 5, 7, and 9 dpi. ABX including 0.25 g/liter vanco-
mycin, 0.5 g/liter neomycin, 0.5 g/liter ampicillin, and 0.5 g/
liter metronidazole (Sigma-Aldrich) were provided continu-
ously via water bottle for 6 wk starting at embryonic day 13. 
To make the ABX palatable, we supplemented control and 
antibiotic water with artificial sweetener (Equal).
Flow cytometry
The left lung lobe, the smallest postcaval lobe, and the me-
diastinal lymph nodes (MLN) were washed separately in 
PBS/2% FCS before mechanical dissociation using a pestle 
and a 70-µm cell strainer (BD Biosciences). Isolated sin-
gle-cell suspensions were washed with PBS/2% FCS, and red 
blood cells were lysed using Gey’s buffer. Cells were washed 
again, followed by incubation with anti-FcγRIII/II (Fc block) 
for 15 min at 4°C. Cells were stained using fluorescently 
labeled antibodies directed against CD45RA-PE (14.8), 
CD4-AF488 or CD4-V500 (RM4-5), Ly6G-FITC (1A8), 
CD8α-PerCP-Cy5.5 (53-6.7), Gr-1–AF488 (RB6-8C5), 
CD11b-AF488 (M1/70), B220-AF488 (RA36B2), 
B220-V500 (RA36B2; all BD Bioscience); CD64-BV421 
(X54-5/7.1), MHC II APC-Cy7 (M5/114.15.2), CD103-PE 
(2E7), CD25-BV605 (PC61), CD3ε-AF488 (145.2CII), 
CD11c-AF488 (N418), CD19-AF488 (6D5), CD45-BV421 
(30-F11), CD11b-BV421 (M1/70), ST-2–APC (DIH9; all 
BioLegend); neurophilin-1–PE or -AF488 (761705; R&D 
Systems); Helios-PE (22F6), CTLA-4–PE (UC10-4B9), 
CD39-PerCP-efluor710 (24DMS1), ICOS-PE (C398.4A), 
Lag3-PerCP-efluor710 (C9B7W), TIG IT-PE (GIGD7), 
PD-1–APC-780 (J43), Siglec-H–Alexa Fluor 647 (ebio440c; 
all eBioscience); and Sema4a-FITC (5E3; MBL). DAPI (Da-
koCytomation), 7-AAD (eBioscience), or Zombie NIR (Bi-
oLegend) were used to exclude dead cells. For intracellular 
staining, cells were fixed and permeabilized using the BD 
Cytofix/Cytoperm kit as per the manufacturer’s instruc-
tions (BD Biosciences) and stained with FoxP3–Alexa Fluor 
647 (MF23; BD Biosciences). For BrdU staining, MLN cells 
were incubated with 300 µg/ml DNase I (Roche) in PBS 
at 37°C, followed by washing and staining with anti–BrdU-
FITC (BU20A; eBioscience). Stained cells were washed and 
acquired using a LSRFortessa X-20 Flow Cytometer (BD 
Biosciences) and analyzed using FACS Diva software v.8 (BD 
Biosciences) and FlowJo v.8.8 (Tree Star). Antigen-presenting 
cell populations were gated as previously described (Plantinga 
et al., 2013), and Sema4a expression was calculated as fold 
increase in median fluorescence intensity over the fluores-
cence minus one control.
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cell sorting and culture
For adoptive transfer experiments, T reg cells (Nrp-1+, CD4+, 
FoxP3-RFP+) were isolated from the MLN of PVM-infected 
FoxP3-RFP mice at 7 dpi. Single-cell suspensions were gener-
ated by digestion of the tissue using a gentleMACS (Miltenyi 
Biotec) as per the manufacturer’s instructions, and RBCs 
were lysed with Gey’s buffer. Cells were washed, blocked with 
Fc Block, enriched using the EasySep Mouse CD4+ T Cell 
Isolation kit (StemCell Technologies) and stained with fluo-
rochrome-labeled antibodies as described in the Flow cytom-
etry section. Zombie-NIR−, Nrp-1+, CD4+, FoxP3-RFP+ T 
reg cells and Zombie-NIR−, CD4+, FoxP3-RFP− T con cells 
were sorted on a BD FAC SAria Fusion. The purity of FACS-
sorted cells was >95% in all cases. 3 × 104 cells or vehicle 
diluent (10% FCS/DMEM) were adoptively transferred (i.p.) 
to individual neonate pDCΔ or WT mice the same day.
For DC, alveolar macrophage, and T cell co-culture ex-
periments, lung, BAL, and MLN cells were harvested from 
WT neonatal mice at 7 dpi, and single-cell suspensions 
were generated by gentle dissociation through a 70-µm cell 
strainer or GentleMACS. To isolate DCs or alveolar mac-
rophages, CD11c+ cells were enriched using the EasySep 
Mouse CD11c Positive Selection kit II (StemCell Technol-
ogies) followed by FACS sorting of pDCs (Lin−, MHC II+, 
F4/80−, CD11b−, Siglec-H+), moDCs (Lin-, MHC II+, 
CD11b+, CD64+, F4/80−), cDCs (Lin−, MHC II+, CD11b+, 
CD64−, F4/80−), and alveolar macrophages (Lin−, MHC II+, 
CD11b−, F4/80+). To isolate CD4+ T cells from the MLN of 
PVM-infected pDCΔ neonatal mice, single-cell suspensions 
were generated, and CD4+ T cells were enriched by MACS 
as described earlier in this section for T cells, before being 
stained with 5  µM CFSE (37°C for 10 min) and washed 
three times. APCs (5 × 103) and CFSE-labeled CD4+ T cells 
(2 × 105) were seeded into a 96-well round-bottom plates 
and cultured for 96 h in standard murine growth medium 
(5 × 10−5 mol/liter RPMI 1640, 10% heat-inactivated FCS, 
2 mmol/liter l-glutamine, 20 mmol/liter Hepes, 100 mg/
ml penicillin, 100 mg/ml streptomycin, and 0.1 mmol/liter 
sodium pyruvate) with 1 µg/ml CD3 and 100 U/ml IL-2 in 
the presence of either anti-Sema4a (757129; R&D Systems) 
or an isotype control (IgG2a; R&D Systems).
For whole MLN assays, single-cell suspensions of MLN 
cells from PVM-challenged mice were cultured at 5 × 105 
cells/well per 200 µl of growth medium (as before) for 3 d. 
Supernatants were analyzed by ELI SA.
Gene expression analysis
The superior right lobe was excised, stored at 4°C overnight 
in RNAlater solution (Ambion), and transferred to −80°C. 
Total RNA was extracted using TriReagent solution (Am-
bion), and DNase digestion was performed using Turbo 
DNase (Ambion) according to the manufacturer’s instructions. 
Reverse transcription was performed using M-MLV reverse 
transcription and random primers (Invitrogen). Quantitative 
real-time PCR was performed with SYBR Green (Applied 
Biosystems) as per the manufacturer’s instructions. Primer 
sequences were as follows: Hprt, forward 5′-AGG CCA GAC 
TTT GTT GGA TTT GAA-3′ and reverse 5′-CAA CTT GCG 
CTC ATC TTA GGC TTT-3′; Sema4a, forward 5′-GAC GAT 
GGC AAC ACT CTC TATG-3′ and reverse 5′-GGC CAG 
GGT ATC ATG TTC TTT-3′. Gene expression was calculated 
using the –ΔΔCt method relative to the housekeeping gene 
Hprt and expressed as fold change compared with naive mice 
of the respective genotype.
cytokine and PVM-specific IgG analysis
The concentration of mouse IFN-α (limit of detection [LOD] 
2.38 pg/ml; PBL Interferon Source); TNF-α (LOD 5 pg/ml; 
eBioscience); active IL-10 (LOD 5 pg/ml), IFN-γ (LOD 4 
pg/ml), IL-6 (LOD 2 pg/ml), IL-17A (LOD 8 pg/ml; all Bi-
oLegend); IL-33 (LOD 14.3 pg/ml) and KC/CXCL1 and 
eotaxin 2/CCL24 (LOD 15.6 pg/ml; all R&D Systems); IL-4 
(LOD 2 pg/ml), IL-5 (LOD 7 pg/ml), IL-13 (LOD 0.274 
pg/ml; all BD Bioscience) was quantified in the BALF or 
lung homogenate by ELI SA or cytometric bead array (IL-
13 only) as per the manufacturer’s instructions. PVM-specific 
IgG titers were detected in mouse sera using a SMA RT-spot 
ELI SA kit, according to the manufacturer’s instructions (Bio-
tech Trading Partners). The concentration of human IL-6 and 
IL-10 (LOD 3.91 pg/ml for both) was quantified in the nasal 
secretions using an in-house ELI SA, as described previously 
(Pritchard et al., 2012).
Immunohistochemistry and histology
Paraffin-embedded sections were prepared as previously de-
scribed (Davidson et al., 2011). For immunostaining, blocking 
was performed with 10% normal goat serum or 10% rab-
bit serum in PBS for 30 min and washed in PBS-Tween 20. 
Primary antibodies against the PVM G protein (gift from 
U. Buchholz, National Institutes of Health, Bethesda, MD), 
FoxP3 (FJK-16s; eBioscience), periostin (Stiny-1; AdipoGen). 
and α-smooth muscle actin (1A4; Sigma-Aldrich) were in-
cubated overnight at 4°C. Sections were washed three times 
in PBS/0.05% Tween-20 before incubation with biotinylated 
anti-mouse polyclonal antibody (Invitrogen; for PVM detec-
tion), goat anti–rabbit IgG-AP (Sigma-Aldrich; periostin), or 
goat anti–mouse IgG-AP (Sigma-Aldrich; α-smooth muscle 
actin). After 60-min incubation at room temperature, sections 
were washed three times, and immunoreactivity was devel-
oped with Fast Red (Sigma-Aldrich) and counterstained 
with Gill’s hematoxylin before mounting with Glycergel 
(DakoCytomation). Digitally scanned sections were analyzed 
using Image Scope Software (Scanscope XT; Aperio). The 
number of positively PVM-stained APCs was quantified and 
expressed as a percentage of APCs of five airways. The total 
number of FoxP3+ cells in the lung parenchyma was counted 
and expressed as the total number of immunoreactive cells 
per square millimeter. For quantification of periostin staining, 
the length of positive staining below the basement membrane 
was expressed as a percentage of the total circumference of 
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the basement membrane of five airways per mouse. Sloughing 
of the airway epithelium was quantified by measuring the 
length of sloughed airway epithelium and expressing this as 
a percentage of the basement membrane length of a single 
airway in at least five airways per mouse. Mucus was iden-
tified by periodic acid–Schiff staining and quantified as the 
length of intraluminal mucus within the inner airway lumen 
as a percentage of the airway circumference. ASM mass and 
collagen deposition around the small airways (defined as a 
circumference <500 µm for neonates and <800 µm for mice 
>7 wk old) was measured using Scanscope XT software and 
expressed as area per micrometer of basement membrane. Im-
ages were captured at 40× or 100× magnification with an 
Olympus microscope (model BX51), a digital camera (Olym-
pus DP70), and DP software (Olympus).
Measurement of Ahr
Mice were mechanically ventilated, and AHR to inhaled 
β-methacholine was determined by alterations in resistance 
by forced oscillation technique as described previously 
(Phipps et al., 2009). In brief, anesthetized animals were tra-
cheotomized and applied to the Flexivent (SCI REQ). Dose 
responses to nebulized methacholine (0.3–10 mg/ml; Sigma- 
Aldrich) were expressed as the percentage change over saline 
control (baseline).
human subjects, nasal swabs, and ethics statement
Samples were prospectively collected from 2-yr-old children 
(interquartile range 1.25–3.86) presenting with acute respira-
tory infection to the Princess Margaret Hospital Emergency 
Department as detailed in Table S1. Samples were obtained 
from previously healthy children as part of an influenza vac-
cine effectiveness study (Blyth et al., 2014, 2016). Ethical ap-
proval for the study was obtained from the ethics committees 
of Princess Margaret Hospital for Children (1761EP), the 
South Metropolitan Area Health Service, and the Western 
Australian Aboriginal Health Information and Ethics Com-
mittee. Bilateral mid-turbinate nasal swabs were collected 
using flocked swabs (Copan Diagnostics). The swab was gen-
tly inserted into the nostril until resistance was felt. The swab 
was rotated several times against the nasal wall. On removal, 
swabs were inserted into a commercial viral transport media 
(UTM TM Viral Transport Media; Copan Diagnostics). All 
samples were frozen at −80°C. Nasopharyngeal samples were 
tested by PCR for respiratory viruses including RSV.
Bacterial dnA isolation from feces and amplicon sequencing
Bacterial DNA was isolated using the repeated bead beating 
plus column (RBB+C) method as previously described (Yu 
and Morrison, 2004). In brief, fecal pellets were collected in 
screwcap DNase/RNase-free tubes containing 1 ml lysis buf-
fer (500 mM NaCl, 50 mM Tris-HCl, pH 8.0, 50 mM EDTA, 
and 4% SDS) and 0.4 g sterile zirconia beads (0.3 g of 0.1 mm 
and 0.1 g of 0.5 mm). The mix was homogenized for 3 min on 
a Mini-Beedbeater (BioSpec Products). The homogenate was 
incubated at 70°C for 15 min with gentle shaking, followed by 
centrifugation at 4°C for 5 min at 16,000 g and transfer to a 
fresh 2-ml Eppendorf tube. Genomic DNA was extracted from 
the supernatant using the Maxwell LEV Blood DNA kit as per 
the manufacturer’s instructions (Promega). DNA quality was 
assessed by agarose gel electrophoresis and spectrophotometry 
(ND-1000; NanoDrop Technologies) or fluorometry (Qubit; 
Life Technologies). The 16S rRNA gene-based libraries were 
prepared for sequencing using the MiSeq system (Illumina) 
according to the manufacturer’s instructions. In brief, the V6–
V8 region of the 16S rRNA gene was PCR amplified using 
the 926F and 1492R primers modified to include overhang 
adapters compatible with the Nextera Index PCR XT kit. 
Each PCR product was purified using Agencourt AMPure XP 
beads, and a subsequent PCR was performed using the Nex-
tera Index PCR XT kit with N7XX and S5XX primers. Each 
PCR product was again purified using Agencourt AMPure XP 
beads, quantified, normalized, and then pooled in equal quanti-
ties. The 16S rRNA gene-based libraries were sequenced at the 
Australian Centre for Ecogenomics (Brisbane, QLD, Australia).
Sequence processing and data collection
The sequences were analyzed using the Quantitative Insights 
Into Microbial Ecology (QII ME) software package on an 
Ubuntu Linux virtual machine (v.5.0.12). In brief, QII ME 
was used to demultiplex and perform quality control of the 
sequence data, and only high-quality full-length sequences 
were further analyzed. The sequences were then clustered into 
operational taxonomic units (OTUs) using a 97% cutoff with 
the open reference OTU picking method, in which individual 
sequences were assigned to their respective OTUs according to 
the Greengenes database. An OTU table containing taxonomic 
and abundance data was generated for each individual sample, 
and OTUs that were not identified as bacteria or archaea and/
or OTUs that comprised ≤0.01% of the total sample sequence 
count were removed. The coverage of each sample was assessed 
by rarefaction, and a normalized subsampled OTU table was 
generated by random sampling to the minimum. The subsa-
mpled OTU table was used to generate taxonomy plots from 
phylum to genus levels and calculate α and β diversities.
ScFA analysis
A known volume of ∼100 µl serum was diluted with ultra-
pure water to a final volume of 200 µl. For fecal samples, 0.1 g 
feces was broken apart in 200 µl ultrapure water using a pi-
pette tip and vortexed for 45 s. Both serum and fecal extracts 
were passed through 0.22-µm filters, and SCFA content was 
determined by injecting 100-µl solute mixed with 11 µl of 
10% formic acid into a gas chromatograph fitted with a polar 
capillary column (DB-FFAP) at 140°C and a flame ionization 
detector at 250°C (Greenberg et al., 1992).
Statistical analyses
Statistical analyses were performed using GraphPad Prism 
v.5.0 with Mann–Whitney U test for nonparametric data or 
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Student’s t test for parametric data as appropriate. When more 
than two groups were compared, data were analyzed using a 
one- or two-way ANO VA with Bonferroni post hoc test as 
appropriate. Correlations were evaluated using a Spearman 
rank correlation analysis. A p-value <0.05 was considered 
statistically significant.
online supplemental material
Fig. S1 shows the gating strategy for pDCs; pDC numbers in 
lung and MLN at 0 and 10 dpi; quantitation of antiviral, Th1, 
Th2, and Th17 cytokines, viral load, neutrophils, and eosin-
ophils in the airways; and CD4 and CD8 T cell numbers in 
lung and MLN. Fig. S2 shows Th1, Th2, and Th17 cytokine 
levels in MLN cultures and BALF at 49 dpi, quantitation of 
periostin immunoreactivity in lung at 49 dpi, enumeration of 
IL-13 (dsRed)– and IL-4 (AmCyan)–producing cells in lung 
and MLN at 49 dpi, and pathological features of asthma at 42 
dpi. Fig. S3 shows RDA plots of microbial communities in 
feces, SCFA levels in nasal aspirates from children with viral 
and nonviral bronchiolitis, the study design for SCFA admin-
istration to neonatal mice, and quantitation of propanoic acid 
(serum), IFN-α (BALF), and pDCs (lung) in neonatal mice. 
Table S1, included as an Excel file, shows the demographics, 
symptoms, and viruses detected in patients with viral bron-
chiolitis and symptomatic subjects with no virus detected.
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